1. Vora A.
Tolperisone
J Assoc Physicians India
2010;
58
: 127-8.
2. Nádor K, Porszász J.
Pharmakologische und pharmakochemische Studien über β- Aminoketone
Arzneim Forsch
1958;
8
: 313.
3. Pórszász J, Nádor K, Gibiszer K, Barankay T.
The pharmacology of Mydeton (Mydocalm1-piperidino-2-methyl-3-p-tolyl-propanone-3), a new interneurone blocking compound
Acta Physiol Hung
1960;
18
: 149-70.
4. Pratzel HG, Alken RG, Ramm S.
Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial
Pain
1996;
67
(2-3)
: 417-25.
5. Melka A, Tekle-Haimanot R, Lambien F.
Symptomatic treatment of neurolathyrism with tolperisone HCL (Mydocalm): a randomized double blind and placebo controlled drug trial
Ethiop Med J
1997;
35
(2)
: 77-91.